Ainos, SG Blocks, and BioXcel Therapeutics are the 3 Penny Stocks to watch on August 7, 2025, based on TipRanks’ Penny Stock Screener tool. Penny stocks are defined as stocks that trade at or below $5 per share and have a market capitalization below $300 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The Penny Stock Screener helps investors scan stocks based on numerous parameters, including Sector, Price Target Upside, Smart Score, Analyst Consensus, Dollar Volume, and Price Change.
We leveraged the tool to pick the top three penny stocks with the highest Dollar Volume as of the close on August 6, 2025. Simply put, Dollar Volume is the number of shares traded on a particular day multiplied by the day’s share price.
Ainos (AIMD) – Ainos is a healthcare company focused on both artificial intelligence (AI) and biotechnology. Ainos specializes in SmellTech, AI diagnostics, and immune therapeutics. On August 6, AIMD had a Dollar Volume of $449.51 million, while its stock price surged by nearly 40%.
Yesterday, Ainos announced that it had received a three-year subscription-based order valued at $2.1 million from ASE Technology (ASX). This order represents the first commercial success of Ainos’ proprietary AI Nose platform in semiconductor manufacturing. Ainos will deploy 1,400 AI Nose units across ASEH’s three major manufacturing sites in Taiwan-Kaohsiung, Zhongli, and SPIL.
SG Blocks (SGBX) – Safe & Green Holdings Corp. operates as a developer, designer, and fabricator of modular structures that are safe, sustainable, and eco-friendly. On Wednesday, SGBX had a Dollar Volume of $374.33 million, while its stock price skyrocketed by nearly 90%.
On August 5, SGBX announced plans to acquire Rock Springs Energy for $35 million. The company signed a non-binding Letter of Intent (LOI) to purchase the refinery along with its associated assets, permits, intellectual property, and related documentation. SGBX stock jumped in reaction to this news.
BioXcel Therapeutics (BTAI) – BioXcel Therapeutics is a biopharmaceutical company that is focused on developing AI-enabled treatments for neuroscience. Yesterday, BTAI had a Dollar Volume of $162.70 million, accompanied by a stock price gain of 11.8%.
On August 6, BioXcel announced that a study on their drug dexmedetomidine was published in the journal Frontiers in Pharmacology. The study showed that dexmedetomidine strongly affects stress-related behaviors linked to psychiatric disorders. This means BioXcel’s drug candidate, BXCL501, which contains dexmedetomidine and is approved by the FDA, could be useful for both acute agitation and chronic stress-related conditions.
To find more penny stocks like these, you can take a look at TipRanks’ Penny Stock Screener tool. It shows a list of all penny stocks, their price movement, and other vital data.